[治疗猫传染性腹膜炎的选择-以前和现在]。

IF 0.4 4区 农林科学 Q4 VETERINARY SCIENCES Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere Pub Date : 2023-10-01 Epub Date: 2023-11-13 DOI:10.1055/a-2147-3999
Daniela Krentz, Michèle Bergmann, Sandra Felten, Katrin Hartmann
{"title":"[治疗猫传染性腹膜炎的选择-以前和现在]。","authors":"Daniela Krentz, Michèle Bergmann, Sandra Felten, Katrin Hartmann","doi":"10.1055/a-2147-3999","DOIUrl":null,"url":null,"abstract":"<p><p>Feline infectious peritonitis (FIP) is one of the most common infectious diseases in cats that is fatal when untreated. So far, there is no legally available effective treatment in Germany. Treatment options include only symptomatic treatment (e. g. glucocorticoids, propentofylline), immunomodulatory approaches (e. g. interferons, polyprenyl immunostimulant), and antiviral chemotherapy with protease inhibitors (e. g. GC376) or nucleoside analogues (e. g. GS-441524, remdesivir). Symptomatic treatment does not cure FIP but may lead to a short-term improvement of clinical signs in a subset of cats. Immunomodulatory treatment has also not shown to be very promising. In contrary, the antiviral compounds GS-441524 and GC376 exhibited significant efficacy in several studies and their use saved the lives of many cats suffering from FIP. However, both agents are currently not licensed and thus cannot be legally administered by veterinarians in Germany. Legally, cats may only be legally treated with GS-441524 in a few countries (e.g. Great Britain and Australia). In other countries, GS-441524 is imported by cat owners via the black market and administered on their own. This article provides an overview of the available treatment options and an outlook on the legal use of effective antiviral drugs.</p>","PeriodicalId":49434,"journal":{"name":"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Options for treatment of feline infectious peritonitis - previously and today].\",\"authors\":\"Daniela Krentz, Michèle Bergmann, Sandra Felten, Katrin Hartmann\",\"doi\":\"10.1055/a-2147-3999\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Feline infectious peritonitis (FIP) is one of the most common infectious diseases in cats that is fatal when untreated. So far, there is no legally available effective treatment in Germany. Treatment options include only symptomatic treatment (e. g. glucocorticoids, propentofylline), immunomodulatory approaches (e. g. interferons, polyprenyl immunostimulant), and antiviral chemotherapy with protease inhibitors (e. g. GC376) or nucleoside analogues (e. g. GS-441524, remdesivir). Symptomatic treatment does not cure FIP but may lead to a short-term improvement of clinical signs in a subset of cats. Immunomodulatory treatment has also not shown to be very promising. In contrary, the antiviral compounds GS-441524 and GC376 exhibited significant efficacy in several studies and their use saved the lives of many cats suffering from FIP. However, both agents are currently not licensed and thus cannot be legally administered by veterinarians in Germany. Legally, cats may only be legally treated with GS-441524 in a few countries (e.g. Great Britain and Australia). In other countries, GS-441524 is imported by cat owners via the black market and administered on their own. This article provides an overview of the available treatment options and an outlook on the legal use of effective antiviral drugs.</p>\",\"PeriodicalId\":49434,\"journal\":{\"name\":\"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.4000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2147-3999\",\"RegionNum\":4,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/11/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tieraerztliche Praxis Ausgabe Kleintiere Heimtiere","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2147-3999","RegionNum":4,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/11/13 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

猫传染性腹膜炎(FIP)是猫中最常见的传染病之一,未经治疗是致命的。到目前为止,在德国还没有合法有效的治疗方法。治疗方案仅包括对症治疗(例如:糖皮质激素,丙烯茶碱),免疫调节方法(例如;干扰素,聚戊烯基免疫刺激剂),以及用蛋白酶抑制剂(如。GC376)或核苷类似物(例如;gs - 441524, remdesivir)。对症治疗不能治愈FIP,但可能导致一小部分猫的临床症状短期改善。免疫调节治疗也没有显示出非常有希望。相反,抗病毒化合物GS-441524和GC376在几项研究中显示出显著的疗效,它们的使用挽救了许多患有FIP的猫的生命。然而,这两种药物目前都没有获得许可,因此在德国兽医不能合法使用。从法律上讲,只有在少数国家(如英国和澳大利亚)才能合法地使用GS-441524治疗猫。在其他国家,GS-441524是由猫主人通过黑市进口并自行管理的。本文概述了可用的治疗方案,并对有效抗病毒药物的合法使用进行了展望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
[Options for treatment of feline infectious peritonitis - previously and today].

Feline infectious peritonitis (FIP) is one of the most common infectious diseases in cats that is fatal when untreated. So far, there is no legally available effective treatment in Germany. Treatment options include only symptomatic treatment (e. g. glucocorticoids, propentofylline), immunomodulatory approaches (e. g. interferons, polyprenyl immunostimulant), and antiviral chemotherapy with protease inhibitors (e. g. GC376) or nucleoside analogues (e. g. GS-441524, remdesivir). Symptomatic treatment does not cure FIP but may lead to a short-term improvement of clinical signs in a subset of cats. Immunomodulatory treatment has also not shown to be very promising. In contrary, the antiviral compounds GS-441524 and GC376 exhibited significant efficacy in several studies and their use saved the lives of many cats suffering from FIP. However, both agents are currently not licensed and thus cannot be legally administered by veterinarians in Germany. Legally, cats may only be legally treated with GS-441524 in a few countries (e.g. Great Britain and Australia). In other countries, GS-441524 is imported by cat owners via the black market and administered on their own. This article provides an overview of the available treatment options and an outlook on the legal use of effective antiviral drugs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.80
自引率
16.70%
发文量
108
期刊介绍: Die Tierärztliche Praxis wendet sich mit ihren beiden Reihen als einzige veterinärmedizinische Fachzeitschrift explizit an den Großtier- bzw. Kleintierpraktiker und garantiert damit eine zielgruppengenaue Ansprache. Für den Spezialisten bietet sie Original- oder Übersichtsartikel zu neuen Therapie- und Operationsverfahren oder den Einsatz moderner bildgebender Verfahren. Der weniger spezialisierte Tierarzt oder Berufseinsteiger findet auf seinen Berufsalltag zugeschnittene praxisbezogene Beiträge in der Fortbildungsrubrik „Aus Studium und Praxis“. Mit dem hervorgehobenen „Fazit für die Praxis“ am Ende jedes Artikels verschafft sich auch der eilige Leser einen raschen Überblick über die wichtigsten Inhalte dieser modern konzipierten Fachzeitschrift mit den vielen hochwertigen, überwiegend farbigen Abbildungen. In jedem Heft ermöglicht ein ATF-anerkannter Fortbildungsartikel den Erwerb einer ATF-Stunde (Akademie für tierärztliche Fortbildung).
期刊最新文献
[A malignant pilomatrixoma in the tonsillar area of a dog]. [Arthroscopic removal of the fragmented medial coronoid process in dogs - Evaluation of treatment results with special reference to postoperative computed tomography and residual particles]. [Canine sterile neutrophilic dermatosis (Sweet-like syndrome): A description of 3 cases]. [Hemophilia A in a male cat with intermittent lameness]. [Nephrectomy in a rabbit with renal adenocarcinoma].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1